Complementary and alternative medicine for advanced prostate cancer

The Urologic Clinics of North America
J Daniell RackleyM Craig Hall

Abstract

Complimentary and alternative medicines (CAM) have increased drastically in popularity in the past decade. These are largely in the form of nutritional supplements. Despite a wealth of information sources on the subject, the fundamental problem with CAM therapies is a dearth of evidence-based medicine. Advanced prostate cancer has significant long-term morbidity, and there is a growing interest in alternative and complimentary forms of therapy that will improve the outcomes of patients who have recurrent or advanced prostate cancer while obviating the need for more toxic forms of therapy. In this article we summarize the use of some of the more common CAM nutritional supplements and review the scientific data that are available to support their use.

References

Jul 31, 1985·Biochemical and Biophysical Research Communications·M M WebberG T James
Aug 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·E AbeT Suda
Jan 1, 1994·Nutrition and Cancer·M J MessinaS Barnes
Feb 5, 1997·Journal of the National Cancer Institute·M J Campbell, H P Koeffler
Apr 16, 1997·Journal of the National Cancer Institute·S K KatiyarR Agarwal
Sep 4, 1997·The New England Journal of Medicine·B Dawson-HughesG E Dallal
Feb 11, 1998·Lancet·E Ernst
May 30, 1998·Proceedings of the Society for Experimental Biology and Medicine·Z ZhaoL A Cohen
Sep 17, 1998·The New England Journal of Medicine·R S DiPaolaM A Gallo
Jun 22, 2000·International Journal of Cancer. Journal International Du Cancer·M R SpitzJ Kagan
Sep 16, 2000·Breast Cancer Research and Treatment·R S ZandE P Diamandis
Nov 4, 2000·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·A de la TailleA E Katz
Sep 25, 2001·BioFactors·G F CombsB W Turnbull
Sep 5, 2002·Journal of the National Cancer Institute·Milos SovakRobert Nagourney
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tomasz M BeerW David Henner
Aug 12, 2003·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·O AustW Stahl
Feb 12, 2004·Cancer Research·Jennifer J HuL Douglas Case
Aug 4, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William K OhEric J Small
Sep 24, 2004·International Journal of Cancer. Journal International Du Cancer·Min ZhangXing Xie
Mar 9, 2005·Annals of the New York Academy of Sciences·Eric A Klein
Mar 25, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hongbo HuJunxuan Lü
May 25, 2005·Cancer·Charles L LoprinziUNKNOWN North Central Cancer Treatment Group
Jul 5, 2005·Urology·Jeremy B WiygulWendy Demark-Wahnefried
Dec 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gary G SchwartzFrank M Torti

❮ Previous
Next ❯

Citations

Jul 26, 2013·Journal of Nutritional Science and Vitaminology·Jinyao ChenLishi Zhang
Feb 2, 2016·Life Sciences·Jasmina MakarevićRoman A Blaheta
Dec 8, 2007·Clinical Journal of Oncology Nursing·Susan Doyle-Lindrud
Sep 27, 2007·Academic Medicine : Journal of the Association of American Medical Colleges·Susan A Gaylord, J Douglas Mann
Jul 17, 2013·International Journal of Molecular Sciences·Nina Pauline HolzapfelDietmar Werner Hutmacher
Nov 11, 2011·The Cochrane Database of Systematic Reviews·Dragan IlicCraig Hassed
Apr 9, 2009·Nature Reviews. Urology·Barrie R CassilethK Simon Yeung

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Urology
W Demark-WahnefriedMark M Moyad
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Simon Wilkinson, Gerald W Chodak
© 2022 Meta ULC. All rights reserved